LBRX
LB Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$25.67
+0.73 ▲ +2.93%
🌙 3월 13일 4:57 PM ET (한국 3/14 05:57)
$26.00
+0.33 ▲ +1.29%
| Index | RUT | P/E | - | EPS (ttm) | - | Insider Own | 25.7% | Shs Outstand | 0.03B | Perf Week | 7.95% |
| Market Cap | 0.65B | Forward P/E | - | EPS next Y | 3.95% | Insider Trans | 332.92% | Shs Float | 0.02B | Perf Month | 6.56% |
| Enterprise Value | 0.34B | PEG | - | EPS next Q | -0.69 | Inst Own | 86.86% | Short Float | 13.91% | Perf Quarter | 20.18% |
| Income | - | P/S | - | EPS this Y | -20.72% | Inst Trans | 12.07% | Short Ratio | 8.51 | Perf Half Y | 48.38% |
| Sales | - | P/B | 2.09 | EPS next 5Y | -10.97% | ROA | - | Short Interest | 2.62M | Perf YTD | 15.32% |
| Book/sh | 12.26 | P/C | 2.07 | EPS past 3/5Y | -109.72% - | ROE | - | 52W High | 0.27% ($25.60) | Perf Year | - |
| Cash/sh | 12.43 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 92.14% ($13.36) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 6.04% 5.59% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.46 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 47.6 | EPS Q/Q | 5.57% | Profit Margin | - | RSI (14) | 62.96 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 47.6 | Sales Q/Q | - | SMA20 | 5.95% ($24.23) | Beta | - | Target Price | $44.5 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 2026/02/25 | SMA50 | 12.63% ($22.79) | Rel Volume | 0.96 | Prev Close | $24.94 |
| Employees | - | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | - | SMA200 | 32.66% ($19.35) | Avg Volume(3M) | 0.31M | Price | $25.67 |
| IPO | 2025/9/11 | Option/Short | No/Yes | Trades | 3784 | Volume | 296,343 | Change | 2.93% |
뉴스 로딩 중...